New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, November 10, 2026

Back to the front page

From X

@StableBread

Fajasy on X

I turned Toast’s $TOST 2027 framework into an adjusted EBITDA estimate, to see what the restaurant software and payments company trades at on next year’s numbers. Incoming CFO Michael Senno will own the 2027 numbers, and he already set the frame on the Q3 call. He said he’s “confident in the 20%+ framework” for recurring gross profit growth (Q4 is guided to 22-24%), but expects “very modest margin progression next year” after a ~36% adjusted EBITDA margin in 2026, since $TOST wants room to keep investing in its newer markets. Those newer markets (enterprise, international, and retail) are nearing $200M of ARR and doubling for a second straight year, per CEO Aman Narang, and Senno said the core business already earns margins over 40%. At $34.67/share, $TOST’s enterprise value is $18.3B ($20.1B market cap on 581M shares, less $1.89B of cash and marketable securities, with no debt), or 21.6x 2026 adjusted EBITDA guidance. In my August 10 update, I said I’d add if a pullback took $TOST down to the high teens on forward EV/EBITDA. On the 2026 guide, that’s ~$29/share, which the stock briefly touched at the start of October. Reading Senno’s “very modest margin progression” as a margin near 2026’s ~36%, 20% recurring gross profit growth would mean ~$1.0B of 2027 adjusted EBITDA. So on 2027 numbers, the stock already trades at ~18x, in the high teens.

Investor Letters

All letters

💥Tead-ering💥

Teads’ revenue fell 26% and its stock dropped 38% as Google AI summaries cut publisher referral traffic, worsening losses and straining its…

TEAD $17MGUTS $13M
PETITION 1 click

The AutoNation Story

AutoNation shed rentals and megastores, focused on dealerships, and retired 91.1% of its shares through buybacks after its 1990s roll-up…

AN $6.1B
Cannibal Stocks 1 click

The 10-Q Fills In the Buyback

Empire State Realty Trust bought $86.1 million of stock through November 6, while corrected sum-of-the-parts values range from $9.12 to…

ESRT $1.3B
Orphan REITs 1 click
BNTC · long

Benitec Biopharma INC

Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.

BNTC $333M
Value Investors Club

Where Are Google and Apple?

Meta’s Muse and rival AI agents are gaining consumer traction, while Apple and Google lack comparable public products and face pressure on…

AAPL $5TGOOGL $3.5T
Emerging Moats Research 7 clicks

Intel Panther Lake Teardown

Intel’s Panther Lake puts 18A PowerVia backside power and RibbonFET GAA transistors into commercial silicon, with logic density similar to…

INTC $287B
SemiAnalysis

Updates

FGPR remains on track, PRTH's management buyout is set at $8.05, and microcap RAVE is described as cheap.

FGPR $210MPRTH $649M
Nat Stewart - Stock Picking Newsletter 9 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 79 of 282

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

360 firms

Sectors

Ordered by how often our editor reaches for them.